Home Messages Index
[Date Prev][Date Next][Thread Prev][Thread Next]
Author IndexDate IndexThread Index

[News] The Ugly Side of Gene Patents is Shown

  • Subject: [News] The Ugly Side of Gene Patents is Shown
  • From: Roy Schestowitz <newsgroups@xxxxxxxxxxxxxxx>
  • Date: Wed, 16 Jun 2010 06:32:15 +0100
  • Followup-to: comp.os.linux.advocacy
  • Newsgroups: comp.os.linux.advocacy
  • User-agent: KNode/4.4.2
Hash: SHA1

United States: Ground-breaking Federal District Court Ruling on Gene Patents

,----[ Quote ]
| Editor: Do you see any of your larger clients 
| selling off some of their patent portfolios?
| Camacho: I see very few of my clients selling 
| off patent assets except in connection with 
| the sale of a portion of the business, which 
| will typically include the portion of the 
| patent portfolio to which it pertained. More 
| often, my clients are finding strategic 
| partnerships in which they can monetize their 
| patent portfolio by licensing the technology 
| in markets that are ancillary or orthogonal to 
| the client's primary market - i.e., they don't 
| want to license the technology to a 
| competitor. However, when a client has a large 
| number of overlapping patents on a particular 
| product and the value of pushing through 
| incremental advances on that particular 
| product is marginal at best, I do see clients 
| choosing to spend less of their IP budget on 
| getting additional patent coverage. 


Cancer gene patent faces legal challenge 



Biotech industry warns about legal challenge

,----[ Quote ]
| ELEANOR HALL: Australia's biotechnology
| industry is warning that the court challenge
| being launched today against the patenting of
| human genetic material could kill off
| investment in the industry.
| Lawyers have begun legal action against four
| biotechnology companies, which co-own the
| patent to the breast cancer gene.
| They say companies shouldn't have the right
| to commercialise the human body.
| But representatives of the biotechnology
| industry say the landmark legal case could
| stifle innovation and investment in important
| medical research.


Think Gene Patents Are Controversial Now? Just Wait

,----[ Quote ]
| Of course, the $1,000 genome is likely
| years away, and those who favor exclusive
| patents on diagnostics say theyâre
| necessary for companies to make their money
| back on research and development.
| But exclusive patents may already be
| keeping some patients in the dark, the WSJ
| article says. It describes a new method of
| genetic testing called chromosomal
| microarrays that can pick up chromosomal
| abnormalities in the genome. Whatâs a
| doctor to do if that kind of analysis
| encompasses a gene thatâs already patented
| â tell the patient or stick to the letter
| of the law?

Version: GnuPG v1.4.10 (GNU/Linux)


[Date Prev][Date Next][Thread Prev][Thread Next]
Author IndexDate IndexThread Index